Increased pathological complete response rate after a long-term neoadjuvant letrozole treatment in postmenopausal oestrogen and/or progesterone receptor-positive breast cancer

Giovanni Allevi,Carla Strina,Daniele Andreis,Vanessa Zanoni,Letizia Bazzola,S Bonardi,Chiara Foroni,Manuela Milani,Mariarosa Cappelletti,F Gussago,Sergio Aguggini,Roberto Giardini,Mario Martinotti,Stephen B. Fox,Adrian L. Harris,Alberto Bottini,Alfredo Berruti,Daniele Generali

Increased pathological complete response rate after a long-term neoadjuvant letrozole treatment in postmenopausal oestrogen and/or progesterone receptor-positive breast cancer

2013

Giovanni Allevi
Carla Strina
Daniele Andreis
Vanessa Zanoni
Letizia Bazzola
S Bonardi
Chiara Foroni
Manuela Milani
Mariarosa Cappelletti
F Gussago
Sergio Aguggini
Roberto Giardini
Mario Martinotti
Stephen B. Fox
Adrian L. Harris
Alberto Bottini
Alfredo Berruti
Daniele Generali

Increased pathological complete response rate after a long-term neoadjuvant letrozole treatment in postmenopausal oestrogen and/or progesterone receptor-positive breast cancer

Keywords:

Medicine
Oncology
Letrozole
Pathology
Breast cancer
Progesterone Receptor Positive
Neoadjuvant therapy
Response rate (survey)
Pathological
Gynecology
Cohort study
Internal medicine
single institution
complete response
Progesterone receptor
Cohort

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations